A Safety Study of LY3372689 Given By Mouth to Healthy Participants

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

This study is being conducted to determine the safety profile of the study drug after it is given by mouth to healthy participants. Blood tests will be performed to check how much LY3372689 gets into the bloodstream and how long the body takes to get rid of it. Each enrolled participant will receive up to 3 doses of LY3372689 or placebo. The study will last about 12 weeks, including screening.

Key facts

Study ID
NCT03819270
Run by
Eli Lilly and Company
People needed
23
Starts
2019-02-05
Expected to finish
2019-06-24
Last updated by the study team
2019-07-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.